You are here:
Drugmakers
#

Drugmakers

Get Alerts

Articles

View all

India battles HIV/AIDS drug shortage as some firms halt supply

Sep 04, 2014

India battles HIV/AIDS drug shortage as some firms halt supply

India is facing a shortage of HIV/AIDS drugs provided under government's free medicine programme after drugmakers halted supplies due to delayed payment #NewsTracker #HIV #AIDS #HIV drugs #Indian drugmakers #NACO #shortage of medicine
Uh oh.. is Ranbaxy in more trouble?

Jan 13, 2014

Uh oh.. is Ranbaxy in more trouble?

The US Food and Drug Administration (FDA) has raised concerns about the manufacturing practices at a factory owned by Ranbaxy Laboratories, the drugmaker said on Monday, sending its shares down to nearly a one-month low. #United States #Ranbaxy #Daiichi Sankyo #US FDA #drugmaker #Toansa
Largest PE investment in Indian pharma: KKR injects $200 mn into Gland Pharma

Nov 28, 2013

Largest PE investment in Indian pharma: KKR injects $200 mn into Gland Pharma

KKR'S latest investment in India underscores the positive outlook for generic drugmakers, despite some concerns about manufacturing quality after the recent crackdown by overseas regulators including the US Food and Drug Administration. #DealStream #Private equity #KKR #Pharma #drugmaker #Gland Pharma
US to hike fees for generic drugmakers from Oct; Indian firms to be hit

Aug 12, 2013

US to hike fees for generic drugmakers from Oct; Indian firms to be hit

Many Indian drugmakers will soon have to bear higher costs for sale of products in American markets, as the US health regulator FDA is hiking the fees for generic drugmakers by up to 48 percent from October. #United States #NewsTracker #US FDA #drugmaker #Indian drugmakers
Ranbaxy $500 mn fine: Why single out India and Ranbaxy?

Jun 05, 2013

Ranbaxy $500 mn fine: Why single out India and Ranbaxy?

Ranbaxy may be facing a potential ban on its generic drugs in United States but however Ranbaxy is not the only company that has faced such a crisis. #WhyNow #Ranbaxy Laboratories #US FDA #generic drugmakers

Wire

View all

Ranbaxy $500 mn fine: Why single out India and Ranbaxy?

Sep 20, 2014

Drugmaker to pay fine of $492 million

BEIJING -- Drugmaker GlaxoSmithKline was fined $492 million Friday for bribing doctors in China, the biggest such penalty ever imposed by a Chinese court. The court sentenced the company's former China manager, Briton Mark Reilly, and four Chinese co... #China #GlaxoSmithKline Inc
Ranbaxy $500 mn fine: Why single out India and Ranbaxy?

Sep 19, 2014

Deerfield drugmaker defies Democrats' anti-inversion effort

Horizon Pharma Inc., a Deerfield-based specialty drugmaker, shifted its corporate address to Ireland Friday, defying a threat by Democratic lawmakers to unwind such maneuvers retroactively... #China #GlaxoSmithKline Inc
Ranbaxy $500 mn fine: Why single out India and Ranbaxy?

Sep 19, 2014

China fines GSK $492 million for bribery

A former executive of drugmaker GlaxoSmithKline and four Chinese co-defendants have been sentenced to prison in a bribery case but may never have to serve that time... #China #GlaxoSmithKline Inc